Coya Therapeutics begins extension phase of ALSTARS trial for COYA 302

​Coya Therapeutics has begun the blinded extension phase of the ALSTARS trial, evaluating the safety and efficacy of COYA 302 as a potential treatment for adults with ALS.

The post Coya Therapeutics begins extension phase of ALSTARS trial for COYA 302 appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.